SCHEMBL14545814

SCHEMBL14545814

CCc1cnn2c(N)cc(N3CC[C@H](C)C3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.48
▸ CCNA2 P20248 1/20 0.48
▸ CDK2 P24941 1/20 0.48
▸ CCNA1 P78396 1/20 0.48
▸ SMPD3 Q9NY59 2/20 0.48
▸ HRH4 Q9H3N8 4/20 0.43
▸ HRH3 Q9Y5N1 4/20 0.40
▸ TYK2 P29597 1/20 0.38
▸ EGLN2 Q96KS0 1/20 0.36
▸ PDE10A Q9Y233 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11930781 0.88 HRH4 (0.57) CHEK1CCNA2CDK2CCNA1HRH4
SCHEMBL14545799 0.82 CHEK1 (0.51) CHEK1CCNA2CDK2CCNA1SMPD3
SCHEMBL14050800 0.77 PDE10A (0.47) PDE10A
SCHEMBL11930795 0.74 PDE10A (0.40) CHEK1CCNA2CDK2CCNA1HRH4
SCHEMBL15184400 0.72 SMPD3 (0.45) SMPD3HRH4HRH3KDM4ENPC1
SCHEMBL15393808 0.72 HRH4 (0.51) SMPD3HRH4HRH3TYK2
SCHEMBL15393799 0.72 HRH4 (0.51) SMPD3HRH4HRH3TYK2
SCHEMBL23152050 0.71 CDK2 (0.58) CHEK1CCNA2CDK2CCNA1
SCHEMBL30886761 0.71 CDK2 (0.46) CHEK1CCNA2CDK2CCNA1SMPD3
SCHEMBL14516590 0.71 HRH4 (0.51) SMPD3HRH4HRH3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback